Roadmap Capital's Stephen Ireland Joins the Board of Perimeter Medical Imaging

Perimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce the addition of Stephen Ireland to their board of Directors.

Mr. Ireland is the Healthcare Principal at Roadmap Capital and brings more than 25 years of experience in healthcare. As the former Senior Vice-President, Business Development at TransTech Pharma, Mr. Ireland managed transactions in 2006 and 2010 with Pfizer and Forest Laboratories, respectively, valued in excess of $2 billion in potential upfront fees and milestones, each with recurring double-digit royalties. Mr. Ireland brings international experience in business development, clinical development, research, sales, marketing and executive management to Perimeter's board.

“I’ve been working with Perimeter for over 18 months now and have watched their team exceed expectations and meet all milestones, since we started our due diligence in the Fall of 2013.  Perimeter is addressing a very important unaddressed clinical challenge facing surgeons.  They have adapted a proven technology in a very unique and defensible way and have a very experienced team with a track record of success.  I am excited to be involved in bringing this important innovation to market.” Mr. Ireland commented.

“Stephen brings a wealth of healthcare operational and strategic experience to the board.  We have had the opportunity to work closely together for some time and his insights have proven extremely valuable. As we move towards launch, we are always looking to strengthen our team and I am extremely pleased that Stephen has agreed to join the board of directors.” said Paul Weber, Perimeter’s President and CEO. 


About Perimeter Medical Imaging Inc. 
Perimeter Medical Imaging develops, patents and commercializes advanced surgical imaging tools that allow surgeons, radiologists and pathologists to better assess microscopic tissue structures during the surgical procedure. Perimeter’s OTIS™ is the only solution that provides clinicians with an ultra-high resolution image of the entire surface of the removed tissue specimen, providing accurate information in real time, enabling better decisions and ultimately reducing the need for follow-on second surgeries. Perimeter is a privately owned Canadian company. For more information, visit www.perimetermed.com.
 

Media Contact
Paul Weber, President and CEO
Perimeter Medical Imaging Inc.
(647) 504-4260


*CAUTION - OTIS™ is an investigational device limited by Federal (or United States) law to investigational use.

kevin chia